Skip to main content
. 2024 Jun 27;14:14815. doi: 10.1038/s41598-024-65612-1

Table 1.

Demographic and clinical baseline characteristics.

Healthy group n = 32 HDO group n = 27 p value
Age, years 34 [30;36] 36 [33;39] 0.049
Height, meters 1.64 [1.60;1.69] 1.66 [1.60;1.70] 0.492
Pre-pregnancy body mass index, kg/m2 22.3 [20.8;24.3] 27.2 [22.2;31.7] 0.001
Cardiovascular risk factors
 Arterial hypertension n (%) n/a 16 (59.3) n/a
 Obesity n (%) n/a 11 (40.7) n/a
 Gestational diabetes n (%) n/a 12 (44.4) n/a
 Type 2 Diabetes n (%) n/a 1 (3.7) n/a
Pharmacological therapy during pregnancy
 Aspirin 4 (12.5) 14 (51.9) 0.002
 Metformin 0 (0.0) 11 (20.0)  < 0.001
 Insulin 0 (0.0) 10 (18.2)  < 0.001
 Beta-blockers 0 (0.0) 2 (7.4) 0.205
 Nifedipine 0 (0.0) 1 (3.7) 0.458
Smoking habits
 Non-smoker n (%) 18 (56.3) 20 (74.1) 0.477
 Smoker n (%) 3 (9.4) 2 (7.4)
 Stopped only during pregnancy n (%) 1 (3.1) 1 (3.7)
 Stopped at pregnancy beginning n (%) 2 (6.3) 2 (7.4)
 Ex-smoker n (%) 8 (25.0) 2 (7.4)
Primiparous women n (%) 15 (46.9) 15 (55.6) 0.604
Pregnancy weeks at delivery 39 [31;33] 39 [38;40] 0.291
Type of delivery
 Vaginal delivery n (%) 19 (59.4) 20 (74.1) 0.279
 Caesarean delivery n (%) 13 (40.6) 7 (25.9)
Evaluation moment
 Pregnancy, weeks 31 [32;39] 32 [32;34] 0.146
 Postpartum, months 7 [6;8] 6 [6;7] 0.033

Values expressed by median [interquartile range].

Significant values are in bold.